Edition:
United Kingdom

Mirati Therapeutics Inc (MRTX.OQ)

MRTX.OQ on NASDAQ Stock Exchange Global Select Market

64.32USD
5:30pm GMT
Change (% chg)

$-0.60 (-0.92%)
Prev Close
$64.92
Open
$64.24
Day's High
$64.60
Day's Low
$63.13
Volume
83,982
Avg. Vol
246,009
52-wk High
$67.03
52-wk Low
$24.65

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.851
Jun '18 0.00 -0.937
Mar '18 9.47 -0.510
FY 2017 Dec '17 0.00 -0.666
Sep '17 0.00 -0.655
Jun '17 0.00 -0.735
Mar '17 0.00 -0.732
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 3 0.00 0.00 0.00 --
Quarter Ending Jun-19 3 0.00 0.00 0.00 --
Year Ending Dec-19 9 1.39 12.50 0.00 8.30
Earnings (per share)
Quarter Ending Mar-19 4 -0.97 -0.88 -1.09 --
Quarter Ending Jun-19 4 -1.04 -0.91 -1.18 --
Year Ending Dec-19 10 -4.00 -3.50 -4.74 -2.55
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 33.71
P/E High - Last 5 Yrs. -- 147.99 49.93
P/E Low - Last 5 Yrs. -- 47.78 24.27
Beta 1.68 1.08 0.90
Price to Sales (TTM) -- 49.51 6.28
Price to Book (MRQ) 4.36 10.16 5.27
Price to Tangible Book (MRQ) 4.36 13.82 6.78
Price to Cash Flow (TTM) -- 52.80 24.84
% Owned Institutions 65.71 3.75 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.83
Payout Ratio(TTM) -- 7.04 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 130.05 9.73
Sales (TTM) vs TTM 1 Yr. Ago -- 47.86 5.88
Sales - 5 Yr. Growth Rate -- 22.77 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 33.65 75.88 47.26
EPS (TTM) vs TTM 1 Yr. Ago 20.31 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.82
Capital Spending - 5 Yr. Growth Rate 12.20 9.25 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.25
Current Ratio (MRQ) 7.86 3.43 3.08
LT Debt to Equity (MRQ) 0.00 18.73 11.39
Total Debt to Equity (MRQ) 0.00 31.43 16.13
Interest Coverage (TTM) -- -43.27 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.29 53.79
Gross Margin - 5 Yr. Avg. -- 60.55 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.24 12.87
Operating Margin (TTM) -- -184.42 6.20
Operating Margin - 5 Yr. Avg. -- -126.68 8.31
Pre-Tax Margin (TTM) -- -175.21 7.17
Pre-Tax Margin - 5 Yr. Avg. -- -132.84 8.61
Net Profit Margin (TTM) -- -181.94 3.31
Net Profit Margin - 5 Yr. Avg. -- -137.24 4.89
Effective Tax Rate (TTM) -- 21.48 22.88
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,651,352 844,195,039
Net Income/Employee (TTM) -1,448,615 652,648 100,058,867
Receivable Turnover (TTM) -- 6.25 5.72
Inventory Turnover (TTM) -- 1.89 3.48
Asset Turnover (TTM) 0.00 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -78.89 6.45 11.08
Return on Assets - 5 Yr. Avg. -84.50 5.52 12.21
Return on Investment (TTM) -91.06 8.99 14.48
Return on Investment - 5 Yr. Avg. -108.20 6.86 15.88
Return on Equity (TTM) -91.23 10.14 15.99
Return on Equity - 5 Yr. Avg. -108.28 8.39 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -10.00 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Mirati Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 190.00 180.00 99 99
13 Week 281.58 263.00 99 95
26 Week 198.97 176.24 99 98
52 Week 139.67 103.14 99 72
YTD 205.26 168.08 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 185
Total Shares Held: 34,943,080
3 Mo. Net Change: 111,833
# New Positions: 2
# Closed Positions: 4
# Increased Positions: 10
# Reduced Positions: 14
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.